Gilead

Vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir are capped at a Gi

Gilead to enroll pediatric patients for late-stage remdesivir study

The trial will assess the effectiveness and safety of the drug in the patients, which would include newborns to adolescents, across more than 30 sites in the United States and Europe.

By REUTERS
17/06/2020
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy